Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-20-001448
Filing Date
2020-02-14
Accepted
2020-02-14 11:30:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8477762_13g-a.htm SC 13G/A 118052
  Complete submission text file 0000919574-20-001448.txt   119607
Mailing Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108
Business Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108 617-622-4003
ZAFGEN, INC. (Subject) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88225 | Film No.: 20615951
SIC: 2834 Pharmaceutical Preparations

Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A